Yahoo
NasdaqGS - Delayed Quote USD

Medpace Holdings, Inc. (MEDP)

656.77 -6.72 (-1.01%)
At close: 4:00:00 PM EST
656.77 0.00 (0.00%)
After hours: 4:00:46 PM EST
Trade MEDP on Coinbase

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Dr. August James Troendle M.D.
CEO, President & Chairman 1.44M 91.65M 1956
Mr. Kevin M. Brady
CFO & Treasurer 646.14k 6.03M 1974
Mr. Stephen P. Ewald J.D.
Chief Compliance Officer, General Counsel & Corporate Secretary 1.02M 7.9M 1969
Mr. Brad W. Hansman
Executive Vice President of Operations -- -- 1983
Chris Carissimi M.B.A.
Chief Information Officer -- -- --
Ms. Lauren Morris
Associate Director of Investors Relations -- -- --
Mr. Todd Meyers
Vice President of Business Development & Marketing -- -- --
Mr. Weimin Gai MS
Senior Vice President of Biometrics -- -- --
Mr. John T. Wynne MBA
Chief Business Officer -- -- --
Ms. Reinilde Heyrman M.D.
Chief Medical Officer of Medical Department -- -- 1961

Medpace Holdings, Inc.

5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911 https://www.medpace.com
Sector: 
Healthcare
Full Time Employees: 
6,600

Description

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Corporate Governance

Medpace Holdings, Inc.’s ISS Governance QualityScore as of November 1, 2026 is 6. The pillar scores are Audit: 6; Board: 8; Shareholder Rights: 5; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 21, 2026 at 8:00 PM UTC

Medpace Holdings, Inc. Earnings Date

Recent Events

October 22, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 21, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 23, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 22, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 4, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 19, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 23, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 22, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 1, 2026 at 12:00 AM UTC

DEFA14A: Proxy Statements

March 16, 2026 at 12:00 AM UTC

PRE 14A: Proxy Statements

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: